These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1313372)

  • 1. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats.
    Ogino K; Hobara T; Ishiyama H; Yamasaki K; Kobayashi H; Izumi Y; Oka S
    Eur J Pharmacol; 1992 Feb; 212(1):9-13. PubMed ID: 1313372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat.
    Kim CD; Hong KW
    J Pharmacol Exp Ther; 1995 Oct; 275(1):340-4. PubMed ID: 7562569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
    Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
    Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils.
    Sakurai K; Osaka T; Yamasaki K
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S90-6. PubMed ID: 16184427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor.
    Udagawa A; Shiota G; Ichiba M; Murawaki Y
    Scand J Gastroenterol; 2003 Feb; 38(2):141-6. PubMed ID: 12678329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of rebamipide on gastric xanthine oxidase activity and type conversion in ethanol-treated rats.
    Huh K; Shin US; Lee SH
    Free Radic Biol Med; 1996; 20(7):967-71. PubMed ID: 8743982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
    Murakami K; Okajima K; Harada N; Isobe H; Okabe H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies indicating antioxidative properties of rebamipide.
    Iinuma S; Naito Y; Yoshikawa T; Takahashi S; Takemura T; Yoshida N; Kondo M
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):35S-39S. PubMed ID: 9753224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antral ulcers induced by alendronate, a nitrogen-containing biphophonate, in rat stomachs - prophylactic effect of rebamipide.
    Ohashi Y; Aihara E; Takasuka H; Takahashi K; Takeuchi K
    J Physiol Pharmacol; 2009 Sep; 60(3):85-93. PubMed ID: 19826186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats.
    Yamasaki K; Ishiyama H; Imaizumi T; Kanbe T; Yabuuchi Y
    Jpn J Pharmacol; 1989 Apr; 49(4):441-8. PubMed ID: 2542684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of rebamipide on ammonia-induced gastric mucosal hemorrhagic lesion in rats.
    Huh K; Kwon TH; Kim SK; Kim JS; Shin US
    Arch Pharm Res; 1998 Feb; 21(1):1-5. PubMed ID: 9875506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of various mucosal protective drugs on diethyldithiocarbamate-induced antral ulcer in rats.
    Oka S; Ogino K; Hobara T; Yoshimura S; Okazaki Y; Takemoto T; Iida Y
    Eur J Pharmacol; 1991 May; 197(1):99-102. PubMed ID: 1654263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rebamipide on lipid peroxidation and gastric mucosal injury induced by indometacin in rats.
    Yoshikawa T; Naito Y; Nakamura S; Nishimura S; Kaneko T; Iinuma S; Takahashi S; Kondo M; Yamasaki K
    Arzneimittelforschung; 1993 Dec; 43(12):1327-30. PubMed ID: 8141822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells.
    Hahm KB; Park IS; Kim YS; Kim JH; Cho SW; Lee SI; Youn JK
    Free Radic Biol Med; 1997; 22(4):711-6. PubMed ID: 9013134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of rebamipide, an antiulcer agent, against activation of human neutrophils exposed to formyl-methionyl-leucyl-phenylalanine.
    Kobayashi T; Zinchuk VS; Garcia del Saz E; Jiang F; Yamasaki Y; Kataoka S; Okada T; Tsunawaki S; Seguchi H
    Histol Histopathol; 2000 Oct; 15(4):1067-76. PubMed ID: 11005231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebamipide induces the gastric mucosal protective factor, cyclooxygenase-2, via activation of 5'-AMP-activated protein kinase.
    Lee S; Jeong S; Kim W; Kim D; Yang Y; Yoon JH; Kim BJ; Min DS; Jung Y
    Biochem Biophys Res Commun; 2017 Jan; 483(1):449-455. PubMed ID: 28011266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.
    Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.
    Takeuchi K; Takayama S; Hashimoto E; Itayama M; Amagase K; Izuhara C
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():37-46. PubMed ID: 25521732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of taurine on indomethacin-induced gastric mucosal injury.
    Son M; Kim HK; Kim WB; Yang J; Kim BK
    Adv Exp Med Biol; 1996; 403():147-55. PubMed ID: 8915352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
    Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
    J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.